A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 280.88%. However, over the past six months, we’ve seen a weaker performance of 514.04%. The price of IPA fallen by 49.71% over the last 30 days. And in the last five days, it has surged by 36.32%.
Currently, the stock price of ImmunoPrecise Antibodies Ltd (IPA) is $2.59. In the most recent trading session, the stock underwent a significant upswing, peaking at $5.0 after opening at $2.57. The stock touched a low of $3.0 before closing at $2.0.
ImmunoPrecise Antibodies Ltd’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $2.41 on 08/18/25, with the lowest value being $0.27 on 03/04/25.
52-week price history of IPA Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. ImmunoPrecise Antibodies Ltd’s current trading price is 7.47% away from its 52-week high, while its distance from the 52-week low is 859.26%. The stock’s price range for this period has been between $0.27 and $2.41. The Healthcare sector company’s shares saw a trading volume of about 6.69 million for the day, which was higher than the average daily volume of 2.49 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
ImmunoPrecise Antibodies Ltd (IPA) has experienced a quarterly rise of 423.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 119.54M and boasts a workforce of 102 employees.
Expert Opinions: Analysts’ Ratings for ImmunoPrecise Antibodies Ltd
As of right now, 0 analyst is rating ImmunoPrecise Antibodies Ltd as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.99, with a change in price of +2.11. Similarly, ImmunoPrecise Antibodies Ltd recorded 1,780,886 in trading volume during the last 100 days, posting a change of +479.55%.
IPA’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for IPA stands at 0.57. Similarly, the long-term debt-to-equity ratio is also 0.49.
IPA Stock Stochastic Average
As of today, the raw stochastic average of ImmunoPrecise Antibodies Ltd over the last 50 days is at 95.33%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 91.16%. Further, the company’s Stochastic %K and %D values for the last 20 days were 67.09% and 58.82%, respectively.
